Dr. Grossberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1438 S Grand Blvd
Saint Louis, MO 63104Phone+1 314-977-4829Fax+1 314-268-5494
Education & Training
- David P. Wohl Memorial Mental Health InstituteResidency, Psychiatry, 1977 - 1979
- SSM Health/Saint Louis University School of MedicineResidency, Psychiatry, 1976 - 1977
- Mercy Hospital (St Louis)Internship, Transitional Year, 1975 - 1976
- Saint Louis University School of MedicineClass of 1975
Certifications & Licensure
- IL State Medical License 1997 - 2026
- MO State Medical License 1976 - 2025
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- St. Louis Magazine: Top Doctors Castle Connolly, 2001
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- 860 citationsThe cholinergic system in the pathophysiology and treatment of Alzheimer's disease.Harald Hampel, M.-Marsel Mesulam, A. Claudio Cuello, Martin R. Farlow, Ezio Giacobini
Brain. 2018-07-01 - 76 citationsThe Natural History of Alzheimer's Disease: A Brain Bank StudyBarbara C. Jost, George T. Grossberg
Journal of the American Geriatrics Society. 1995-11-01 - 24 citationsDrinking behavior and vasopressin responses to hyperosmolality in Alzheimer's disease.Stewart G. Albert, B. R. S. Nakra, George T. Grossberg, Eduardo R. Caminal
International Psychogeriatrics. 1994-01-01
Journal Articles
- The Cholinergic System in the Pathophysiology and Treatment of Alzheimer’s DiseaseGeorge T Grossberg, Peter J Snyder, Martin R Farlow, Brain
Press Mentions
- New Data on IV Ketamine for Resistant Depression in the ElderlyMarch 14th, 2023
- LUCIDITY Phase 3 Topline Data Presented at CTAD for HMTM - the Only Oral Anti-Tau Therapy in Late-Stage DevelopmentNovember 30th, 2022
- Avoiding Alzheimer’s: Lifestyle Modifications You Can Make TodaySeptember 22nd, 2022
- Join now to see all
Other Languages
- Hebrew, Hungarian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: